Medicinal cannabis sales on track to double in 2021 by Martin Lane April 1, 2021April 26, 2024 Medicinal cannabis sales will double in 2021, driven by a rapid growth in patient numbers and […]
Patience the watchword as companies line up to put S3 visions to the test by Steve Jones March 30, 2021April 26, 2024
The Green Room: how to respond to anti-cannabis invective by Martin Lane March 26, 2021April 26, 2024
Medicinal cannabis and chronic pain: absence of evidence is not evidence of absence by Rhys Cohen March 25, 2021April 26, 2024
Cannabis industry hits back: pain management claims are putting patients at risk by Martin Lane March 24, 2021April 26, 2024
‘Reputation arrives on foot, and leaves on horseback’: industry urged not to rush to profitability by Steve Jones March 18, 2021April 26, 2024
Only one new cannabis format brought to market in the last six months by Martin Lane March 18, 2021April 26, 2024
Chief scientist calls on MCIA to draw up research strategy to tackle ‘uniquely Australian challenges’ by Steve Jones March 18, 2021April 26, 2024
